PEGylated Mesoporous Silica Nanoparticles (MCM-41): A Promising Carrier for the Targeted Delivery of Fenbendazole into Prostrate Cancer Cells

Low water solubility and bioavailability limit the clinical application of drugs. Solubilizing agents, such as Mobil Composition of Matter Number 41 (MCM) as a drug carrier, can improve the water solubility of the drugs. In this study, PEGylated MCM nanoparticles were synthesised and loaded with fenbendazole, which is a potential anticancer drug, to improve its solubility and, as a result, its cytotoxicity effect against human prostate cancer PC-3 cells.

All data related to this study are contained within the article, "Esfahani, Maedeh Koohi Moftakhari, Alavi, Seyed Ebrahim, Cabot, Peter J., Islam, Nasrul, & Izake, Emad L. (2021) PEGylated Mesoporous Silica Nanoparticles (MCM-41): A Promising Carrier for the Targeted Delivery of Fenbenzadole into Prostrate Cancer Cells. Pharmaceutics, 13(10), Article number: 1605. ".